Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Intercept Pharmaceuticals Inc. (ICPT)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

403,688 $50,025 23.96%
2.
Ikarian CapitalPUT

Neil Shahrestani

754,900 $93,547 15.15%
3. 1,219,121 $151,073 +5% 10.27%
4. 860,000 $106,571 +2% 8.84%
5.
LMR Partners

Ben Levine, Andrew Manuel And Stefan Renold

14,000,000 $1,858,500 3.04%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$60.32 5,207 Director 403,688 2019-08-28 Filing
$64.30 1,180 Director 398,481 2019-08-22 Filing
$67.12 29,000 Director 397,301 2019-08-21 Filing
$65.85 37,604 Director 368,301 2019-08-20 Filing
$83.50 1,200 Director 7,556 2019-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$94.04 723 Officer 17,837 2020-01-27 Filing
$113.02 732 Officer 6,303 2020-01-07 Filing
$125.00 100 Officer, Director 469,126 2019-12-31 Filing
$125.00 262 Officer 18,722 2019-12-31 Filing
$117.16 259 Officer 10,580 2019-01-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,485,000 $4,611 2.31%
2. 290,731 $36,028 1.51%
3. 50,260 $6,228 1.43%
4. 715,176 $88,624 1.4%
5. 1,222 $15,143 1.33%
News See All